| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4028454 | Ophthalmology | 2008 | 11 Pages |
Abstract
Among patients receiving care for AMD at a tertiary retinal center, more than one third of those deemed candidates for AREDS-type supplements were not using them or were using an incorrect dose. Furthermore, nearly one fifth of participants who were using high-dose supplements did not have a level of AMD anticipated to benefit from usage. Increased patient education is needed regarding the recommendations of AREDS.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Leon D. MD, Emily W. PhD, Sharon D. MD, Andrew P. MD, Neil M. MD, Susan B. MD,